The COVID-19 pandemic has profound adverse effects on the population on dialysis.
Patients requiring dialysis are at an increased risk of SARS-CoV-2 infection and mortality …

Infection is the second leading cause of death in patients with chronic kidney disease (CKD).
Adequate humoral (antibody) and cellular (T cell-driven) immunity are required to minimize …

Background Immunocompromised patients are at increased risk of severe COVID-19 and
impaired vaccine response. In this observational prospective study, we evaluated …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has infected over 600 million individuals and caused …

Background Chronic kidney disease (CKD) patients are at high-risk for severe coronavirus
disease 2019 (COVID-19). The multicentric, observational and prospective SENCOVAC …

Neutralizing antibodies are considered a correlate of protection against SARS-CoV-2
infection and severe COVID-19, although they are not the only contributing factor to …

Results During the first wave, incidence in dialysis patients was approximately proportional
to the general population. However, we showed a lower relative incidence for dialysis …

Introduction: Coronavirus disease is associated with increased morbidity and mortality in
maintenance hemodialysis (MHD) patients. Recent breakthrough infection in vaccinated …

Background Patients with chronic kidney disease (CKD) or kidney replacement therapy
demonstrate lower antibody levels after severe acute respiratory syndrome coronavirus 2 …

Despite progressive improvements in the management of patients with coronavirus disease
2019 (COVID-19), individuals with end-stage kidney disease (ESKD) are still at high risk of …